Democratic Sens. Elizabeth Warren and Tina Smith have asked nine pharmacy benefit managers, including Express Scripts, CVS Health and OptumRx, to respond to recent claims by Health and Human Services Secretary Alex Azar.
According to a Fierce Healthcare report, the senators want the PBMs to address statements made by Azar last month in which he accused the companies of hampering drugmakers’ efforts to voluntarily lower prices.
“I would encourage the Senate and Congress to inquire of pharmacy benefit managers as to whether they have received suggestions or approaches from drug companies for lower list prices and what has the reaction been,” he said in a Senate Finance Committee hearing last week.
The senators in their letters say the allegations could raise antitrust concerns.
“These are extremely disturbing allegations by Secretary Azar,” the senators write. “If they are true, these allegations suggest that PBMs and drug distributors are acting to maintain high list prices in order to maintain high profit margins, potentially raising antitrust concerns.”
Read the full report on Fierce Healthcare click here.
To read the letter, click here.